Zepzelca 4 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJE9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,081
Award facts
- Contract value 100% obligated
- $10,080.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,080.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zepzelca 4 mg vials, with completion targeted for January 14, 2026. This competitively awarded, non-set-aside contract is performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, leverages its IDC with the Defense Logistics Agency to fulfill diverse pharmaceutical supply needs across the military health system. The SPE2DX contract enables the company to deliver a broad spectrum of medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for Zepzelca, an oncology medication, represents a routine transaction within the contractor's extensive portfolio of federal pharmaceutical deliveries, demonstrating AmerisourceBergen's capability to meet specialized medical supply requirements through competitive federal procurement processes.
Quick answers
Who was awarded contract SPE2DR26FJE9Q?
SPE2DR26FJE9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FJE9Q worth?
The government has obligated $10,081 on SPE2DR26FJE9Q.
Is contract SPE2DR26FJE9Q an order under another contract?
Yes. SPE2DR26FJE9Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJE9Q competed?
The extent of competition for SPE2DR26FJE9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award